Dapagliflozin Propanediol Monohydrate (Eq. to Dapagliflozin 5mg/10mg) is a medication used primarily to manage type 2 diabetes mellitus and heart failure.

Dapagliflozin is an SGLT2 (sodium-glucose co-transporter 2) inhibitor, which works by blocking the SGLT2 protein in the kidneys, preventing glucose from being reabsorbed back into the bloodstream. Instead, excess glucose is excreted in the urine, helping to lower blood sugar levels.
In addition to its role in managing diabetes, Dapagliflozin has shown benefits in treating heart failure with reduced ejection fraction and chronic kidney disease, as it helps reduce the risk of hospitalization for heart failure and slows the progression of kidney disease. It is typically prescribed in 5mg or 10mg doses, depending on the patient’s medical condition and the desired therapeutic effect. It can be used alone or in combination with other anti-diabetic medications.